We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
–
AUM
$2.28B
AUM Growth
+$52.6M
Cap. Flow
+$6.26M
Cap. Flow %
0.27%
Top 10 Hldgs %
23.01%
Holding
354
New
25
Increased
114
Reduced
145
Closed
16

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$20.5M
2
FTV icon
Fortive
FTV
+$17.9M
3
SU icon
Suncor Energy
SU
+$15.5M
4
CMCSA icon
Comcast
CMCSA
+$11.1M
5
WY icon
Weyerhaeuser
WY
+$7.95M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$18.6M
2
WFC icon
Wells Fargo
WFC
+$10.9M
3
DHR icon
Danaher
DHR
+$10M
4
MKC icon
McCormick & Company Non-Voting
MKC
+$8.37M
5
BUD icon
AB InBev
BUD
+$7.96M

Sector Composition

Rank Sector Weight
1 Healthcare 16.7%
2 Industrials 13.08%
3 Consumer Staples 12.08%
4 Technology 11.11%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
301
Alnylam Pharmaceuticals
ALNY
$29.3B
$279K 0.01%
4,115
– –
BIP icon
302
Brookfield Infrastructure Partners
BIP
$18B
$273K 0.01%
13,223
-4
-0% -$77
PNR icon
303
Pentair
PNR
$11B
$272K 0.01%
+6,313
New +$266K
MCHP icon
304
Microchip Technology
MCHP
$46B
$270K 0.01%
8,700
– –
IHE icon
305
iShares US Pharmaceuticals ETF
IHE
$1.64B
$269K 0.01%
5,400
– –
AKAM icon
306
Akamai
AKAM
$15.9B
$265K 0.01%
+5,000
New +$268K
EW icon
307
Edwards Lifesciences
EW
$51.7B
$264K 0.01%
6,570
-450
-6% -$16.9K
RSP icon
308
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$264K 0.01%
3,155
-550
-15% -$45.8K
GS icon
309
Goldman Sachs
GS
$303B
$261K 0.01%
1,615
+50
+3% +$8.13K
CLX icon
310
Clorox
CLX
$12.7B
$258K 0.01%
+2,059
New +$270K
EWC icon
311
iShares MSCI Canada ETF
EWC
$6.33B
$257K 0.01%
+10,000
New +$253K
C icon
312
Citigroup
C
$226B
$256K 0.01%
+5,423
New +$247K
GATX icon
313
GATX Corp
GATX
$6.27B
$252K 0.01%
+5,650
New +$249K
MORN icon
314
Morningstar
MORN
$7.53B
$250K 0.01%
3,160
– –
XLF icon
315
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$249K 0.01%
12,903
-1,795
-12% -$37K
PSX icon
316
Phillips 66
PSX
$81.4B
$245K 0.01%
3,038
-500
-14% -$38.9K
PACB icon
317
Pacific Biosciences
PACB
$370M
$224K 0.01%
+25,000
New +$209K
FDX icon
318
FedEx
FDX
$75.4B
$223K 0.01%
+1,279
New +$209K
TEVA icon
319
Teva Pharmaceuticals
TEVA
$41.2B
$219K 0.01%
4,750
– –
WEC icon
320
WEC Energy
WEC
$35.1B
$219K 0.01%
3,662
– –
BPL
321
DELISTED
Buckeye Partners, L.P.
BPL
$219K 0.01%
+3,055
New +$217K
UL icon
322
Unilever
UL
$136B
$215K 0.01%
4,029
-178
-4% -$9.4K
CCJ icon
323
Cameco
CCJ
$42.4B
$214K 0.01%
25,045
– –
XLP icon
324
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$213K 0.01%
4,010
– –
SABR icon
325
Sabre
SABR
$835M
$212K 0.01%
7,525
– –
11 12
13
14 15

Similar funds

PCH
PGIM Custom Harvest Newark, New Jersey $6.4B AUM 18.53% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
GT
Glenview Trust Louisville, Kentucky $6.37B AUM 23.72% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
EC
ECP ControlCo Summit, New Jersey $6.34B AUM 19.72% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return

Bradley Foster & Sargent's Q3 2016 Portfolio in Review

As of Q3 2016, Bradley Foster & Sargent held 354 positions worth $2.28B, up 2.4% from $2.23B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Bradley Foster & Sargent's Q3 2016 filing shows 25 new, 114 increased, 145 reduced and 16 closed positions. Its largest new stake was IQVIA: 270,634 shares worth $21.9M. The largest sale was CVS Health, an estimated $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Staples.

  • Bradley Foster & Sargent's largest Q3 2016 buy was IQVIA: 270,634 shares worth $21.9M.
  • Bradley Foster & Sargent added most to Comcast in Q3 2016, an estimated $11.1M increase.
  • Bradley Foster & Sargent's biggest Q3 2016 reduction was CVS Health, cutting an estimated $18.6M.
  • Bradley Foster & Sargent fully exited COLUMBIA PIPELINE GROUP IN COM STK (DE) in Q3 2016, selling an estimated $3.19M.
  • Bradley Foster & Sargent's ten largest holdings make up 23% of its $2.28B portfolio in Q3 2016.
  • Bradley Foster & Sargent opened 25 new positions and closed 16 in Q3 2016.
  • Bradley Foster & Sargent's portfolio value rose 2.4% quarter-over-quarter to $2.28B.

Based on Bradley Foster & Sargent's 13F filing for Q3 2016, filed 31 Oct 2016.